Effect of concurrently coadministered drugs on the pharmacokinetic/pharmacodynamic profile of centchroman, a nonsteroidal oral contraceptive, in rats

Contraception

Volumn 74, Issue 2, 2006, Pages 165-173

  Kumar, Vipul ^a   Lal, Jawahar ^a   Singh, Man Mohan ^a   Gupta, Ram Chandra ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

7 Desmethyl centchroman; Amlodipine; Amoxicillin; Atenolol; Cefixime; Centchroman; Ciprofloxacin; Glibenclamide; Interaction; Metformin; Metronidazole; Pioglitazone; Theophylline

Indexed keywords

AMLODIPINE; AMOXICILLIN; ATENOLOL; CEFIXIME; CENTCHROMAN; CIPROFLOXACIN; GLIBENCLAMIDE; METFORMIN; METRONIDAZOLE; ORAL CONTRACEPTIVE AGENT; PIOGLITAZONE; POSTCOITUS CONTRACEPTIVE AGENT; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; ESTROGEN ACTIVITY; EVALUATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NIDATION; NONHUMAN; ORAL CONTRACEPTION; OVARIECTOMY; RAT; SERUM; SPERM; VALIDATION PROCESS;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CENTCHROMAN; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, POSTCOITAL; DRUG INTERACTIONS; EMBRYO IMPLANTATION; ESTROGEN ANTAGONISTS; ETHINYL ESTRADIOL; FEMALE; MALE; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33745943266     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2006.02.007     Document Type: Article

References (38)

1. Ray S., Grover P.K., and Anand N. New synthesis of cis- and trans-3-phenyl-4-[4-(β-pyrolidinoethoxy) phenyl]-7-methoxy chromans. Indian J Chem 9 (1971) 727-728
2. Ray S., Grover P.K., Kamboj V.P., Setty B.S., Kar A.B., and Anand N. Antifertility agents: 12. Structure activity relationship of 3,4-diphenyl chromenes and chromans. J Med Chem 19 (1976) 276-279
3. Kamboj V.P., Kar A.B., Ray S., Grover P.K., and Anand N. Antifertility activity of 3-4-trans-2,2-dimethyl-3-phenyl-4-[4-(β-pyrolidinoethoxy)phenyl]-7-methoxychromans. Indian J Exp Biol 9 (1971) 103-105
4. Singh M.M. Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders. Med Res Rev 21 (2001) 302-347
5. Singh M.M., Bhalla V., Wadhwa V., and Kamboj V.P. Effect of centchroman on tubal transport and pre-implantation embryonic developments in rats. J Reprod Fertil 76 (1986) 317-324
6. Singh M.M., and Kamboj V.P. Fetal resorption in rats treated with an antiestrogen in relation to luteal phase nidatory estrogen secretion. Acta Endocr 126 (1992) 444-450
7. Trivedi R.N., Chauhan S.C., Dwivedi A., Maitra S.C., Kamboj V.P., and Singh M.M. Time related effects of a triphenylethylene antiestrogen on estrogen induced changes in uterine weight, estrogen receptors and endometrial sensitivity in immature rats. Contraception 51 (1995) 367-379
8. Chauhan S.C., Singh M.M., Maitra S.C., and Kamboj V.P. Inhibition of progesterone induced development of giant mitochondria in uterine glandular epithelial cells by an antiestrogen in rat. Contraception 54 (1996) 259-264
9. Singh M.M., Sreenivasulu S., and Kamboj V.P. Duration of anti-implantation action of a triphenylethylene antiestrogen centchroman in adult female rats. J Reprod Fertil 100 (1994) 367-374
10. Singh M.M., Chauhan S.C., Maitra S.C., Trivedi R.N., and Kamboj V.P. Correlation of pinopod development on uterine luminal epithelial surface with hormonal events and endometrial sensitivity in rat. Eur J Endocr 135 (1996) 107-117
11. Singh M.M., Trivedi R.N., Chauhan S.C., Srivastava V.M.L., and Kamboj V.P. Uterine estradiol and progesterone receptor concentration, activities of certain antioxidant enzymes and dehydrogenases and histoarchitecture in relation to time of secretion of nidatory estrogen and high endometrial sensitivity in rat. J Steroid Biochem Mol Biol 59 (1996) 215-224
12. Bansode F.W., Chauhan S.C., Makke A., and Singh M.M. Uterine luminal epithelial alkaline phosphatase activity and pinopod development in relation to endometrial sensitivity in rat. Contraception 58 (1998) 61-68
13. In: Puri V., Kamboj V.P., Chandra H., et al. (Eds). Pharmacology for health in Asia (1988), Allied Publishers, India 439-447
14. Nityanand S., Wati C., Singh L., Srivastava J.S., and Kamboj V.P. Clinical evaluation of centchroman: a new oral contraceptive. In: Puri C.P., and Van Look P.F.A. (Eds). Hormone antagonists for fertility regulation (1988), Indian Society Study Reproduction and Fertility, Bombay (India) 123-124
15. Kamboj V.P., Ray S., and Dhawan B.N. Centchroman. Drugs Today 28 (1992) 227-232
16. Kamboj V.P., Setty B.S., Chandra H., Roy S.K., and Kar A.B. Biological profile of centchroman - a new postcoital contraceptive. Indian J Exp Biol 15 (1977) 1141-1150
17. Misra N.C., Nigam P.K., Gupta R., Aggarwal A.K., and Kamboj V.P. Centchroman - a nonsteroidal anticancer agent for advanced breast cancer - Phase II study. Int J Cancer 43 (1989) 781-783
18. Gosh R., Kamboj V.P., and Singh M.M. Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by metronidazole in female Sprague-Dawley rats. Contraception 64 (2001) 261-269
19. Khurana M., Lal J., Singh M.M., Paliwal J.K., Kamboj V.P., and Gupta R.C. Evaluation of interaction potential of certain concurrently administered drugs with pharmacological and pharmacokinetic profile of centchroman in rats. Contraception 66 (2002) 47-56
20. Freireich E.J., Gehan E.A., Rall D.P., Schmidt L.H., and Skipper H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemother Rep 50 (1966) 219-244
21. Lal J., Paliwal J.K., Grover P.K., and Gupta R.C. Simultaneous liquid chromatographic determination of centchroman and its 7-demethylated metabolite in serum and milk. J Chromatogr B Biomed Sci Appl 658 (1994) 193-197
22. Bailer A.J. Testing for the equality of area under the curve when using destructive measurement techniques. J Pharmacokinet Biopharm 16 (1988) 303-309
23. Bolton S. Statistical inference: estimation and hypothesis testing. In: Swarbrick J. (Ed). Pharmaceutical statistics: practical and clinical applications (1997), Marcel Dekker, New York 148-156
24. Oberle R.L., and Amidon G.L. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine: an explanation of the double peak phenomenon. J Pharmacokinet Biopharm 15 (1987) 529-545
25. Garg D.C., Weidler D.J., and Eshelman F.N. Ranitidine bioavailability and kinetics in normal male subjects. Clin Pharmaol Ther 33 (1983) 445-452
26. Hammarlund M.M., Paalzow L.K., and Odlind B. Pharmacokinetics of furosemide in man after intravenous and oral administration: application of moment analysis. Eur J Clin Pharmacol 26 (1984) 197-207
27. Bergstron R.F., Kay D.R., Harkcom T.M., and Wagner J.G. Penicillamine pharmacokinetics in normal subjects. Clin Pharmacol Ther 30 (1981) 404-413
28. Piquette-Miller M., and Jamali F. Pharmacokinetics and multiple peaking of acebutolol enantiomers in rats. Biopharm Drug Dispos 18 (1977) 543-556
29. Plusquellec Y., Campistron G., Staveris S., et al. A double peak phenomenon in the pharmacokinetics of veralipride after oral administration; a double-site model for drug absorption. J Pharmacokinet Biopharm 15 (1987) 225-239
30. Wang Y., Roy A., Sun L., and Lau C.E. A double peak phenomenon in the pharmacokinetics of alprazolam after oral administration. Drug Metab Dispos 27 (1999) 855-859
31. Imbimbo B.P., Daniotti S., Vidi A., Foschi D., Saporiti F., and Ferrante L. Discontinuous oral absorption of cimetroprium bromide, a new antispasmodic drug. J Pharm Sci 75 (1986) 680-684
32. Veng-Pedersen P. Pharmacokinetics and bioavailability of cimetidine in humans. J Pharm Sci 69 (1980) 394-398
33. Veng-Pedersen P. Pharmacokinetic analysis by linear system approach: I. Cimetidine bioavailability and second peak phenomenon. J Pharm Sci 70 (1981) 32-38
34. Paliwal J.K., and Gupta R.C. Tissue distribution and pharmacokinetics of centchroman, a new nonsteroidal postcoital contraceptive agent and its 7-desmethyl metabolite in female rats after a single oral dose. Drug Metab Dispos 24 (1996) 148-155
35. The Merck index. Centchroman (no. 2018). 12th ed. In: Budavari S. (Ed) (1996), Merck Co. Inc, Whitehouse Station (NJ) 327
36. Houston J.B., Upshall D.G., and Bridges J.W. Further studies using carbamate esters as model compounds to investigate the role of lipophilicity in the gastrointestinal absorption of foreign compounds. J Pharmacol Exp Ther 195 (1975) 67-92
37. Ratna S., Mishra N.C., Roy S.K., and Ray S. Centchroman: tissue distribution and excretion profile in albino rats after oral and intravenous administration. J Basic Appl Med 2 (1994) 31-36
38. Davies B., and Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 10 (1993) 1093-1095